Evidence map›Paper›PMID 21151033›Full record

ReviewNature reviews. Immunology2011

The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Nicole Baumgarth

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 539 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
539citing papers in PubMed, 1 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

539 citing papers in PubMed, 1 synthesis or guideline pooled it, 946 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. B1 Cells for Life.Immunological reviews · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Advances and challenges of ferroptosis in tumor immunity.Journal of physiology and biochemistry · 2026
    Review
  10. A distinct TCRiScience · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Do human B-1 lymphocytes truly exist?Frontiers in immunology · 2026
    Review
  16. Article
  17. Neonatal CD19Frontiers in immunology · 2026
    Article
  18. Article
  19. Article
  20. Article

479 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Nicole BaumgarthCenter for Comparative Medicine, University of California, Davis, California 95616, USA. nbaumgarth@ucdavis.edu
University of California, Davis · US

Funding

Regulation of Humoral Immunity to Influenza VirusR01AI051354 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMGARTH, NICOLE · 2002 to 2012
$3.0M
Humoral responses to Lyme Borreliosis: A mouse modelR01AI073911 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BARTHOLD, STEPHEN WILLIAM, BAUMGARTH, NICOLE · 2008 to 2012
$1.9M
NIAID NIH HHS AI051354NIAID NIH HHS AI073911NIAID NIH HHS R01 AI051354
6 · The paper itself

Abstract

During their development, B and T cells with self-reactive antigen receptors are generally deleted from the repertoire to avoid autoimmune diseases. Paradoxically, innate-like B-1 cells in mice are positively selected for self-reactivity and form a pool of long-lived, self-renewing B cells that produce most of the circulating natural IgM antibodies. This Review provides an overview of the developmental processes that shape the B-1 cell pool in mice, outlines the functions of B-1 cells in both the steady state and during host defence, and discusses possible functional B-1 cell homologues that exist in humans.

Indexed as

AnimalsB-LymphocytesB-Lymphocyte SubsetsHumansImmunoglobulin AImmunoglobulin MLymphocyte ActivationMiceSelf ToleranceImmunoglobulin AImmunoglobulin M

Identifiers

PMID21151033
OpenAlexW2023502808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.